Advent France Biotech raises $70M in first close of new seed fund
DUBLIN – French biotech has a new source of cash for early stage ventures. Advent France Biotechnology (AFB) has raised €64.75 million (US$69.7 million) in a first closing of a new seed fund, which has a mandate to back first or best-in-class breakthrough innovations that address unmet medical needs.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST